Related LncRNAs |
ID |
lncRNA Name |
Disease |
Method |
Sample |
Expression pattern |
Dysfunction type |
Description |
PMID |
Source |
EL0289 |
CDKN2B-AS1 |
Stroke |
N/A |
N/A |
N/A |
expression |
Significantly reduced expression of all INK4/ARF transcripts (p15(INK4b), p16(INK4a), ARF and ANRIL) was found in PBTL of individuals harboring a common SNP (rs10757278) associated with increased risk of coronary artery disease, stroke and aortic aneurysm. |
19343170 |
LncRNADisease
|
EL0289 |
CDKN2B-AS1 |
Stroke |
N/A |
N/A |
N/A |
mutation |
Risk SNPs (rs3217992, A>G;rs1063192, C>T) for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of ANRIL. |
20386740 |
LncRNADisease Lnc2Cancer
|
EL0289 |
CDKN2B-AS1 |
Stroke |
N/A |
N/A |
N/A |
mutation |
Variants (rs3217992, A>G;rs1063192, C>T) on chromosome 9p21.3 correlated with ANRIL expression contribute to stroke risk and recurrence in a large prospective stroke population. |
22034006 |
LncRNADisease
|
EL0289 |
CDKN2B-AS1 |
Stroke |
N/A |
N/A |
N/A |
mutation |
Moreover, genome-wide association studies have demonstrated that the 9p21 genomic locus is a hotspot for the risk of stroke, glioma, plexiform neurofibroma and other disorders |
22814587 |
LncRNADisease
|
EL0289 |
CDKN2B-AS1 |
Stroke |
N/A |
N/A |
N/A |
expression |
Genetic variants that affect the expression of the ANRIL transcript have been correlated with stroke risk and recurrence in a large prospective study |
22817756 |
LncRNADisease
|
EL0289 |
CDKN2B-AS1 |
Stroke |
N/A |
N/A |
N/A |
mutation |
Genetic variation in lncRNA genes causes disease and influences susceptibility |
23791884 |
LncRNADisease
|
EL0289 |
CDKN2B-AS1 |
Stroke |
N/A |
N/A |
N/A |
expression |
Levels of CDKN2B-AS1/ANRIL in human carotid atherosclerotic plaques and peripheral blood T lymphocytes are linked to rates of ischemic and hemorrhagic stroke. |
24145019 |
LncRNADisease
|
|